14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ABVC
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

ABVC BioPharma, Inc. stock price fell more than -6.09% Friday closing at $1.08
(Updated on May 03, 2024)

Sell candidate since Apr 30, 2024 Loss -13.60% PDF

The ABVC BioPharma, Inc. stock price fell by -6.09% on the last day (Friday, 3rd May 2024) from $1.15 to $1.08. During the last trading day the stock fluctuated 7.48% from a day low at $1.07 to a day high of $1.15. The price has been going up and down for this period, and there has been a 9.08% gain for the last 2 weeks. Volume has increased on the last day by 121 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 413 thousand shares were bought and sold for approximately $446.06 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.98 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -5.30% during the next 3 months and, with a 90% probability hold a price between $0.92 and $1.50 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ABVC Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The ABVC BioPharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $1.29 and $1.20. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, April 25, 2024, and so far it has fallen -32.08%. Further fall is indicated until a new bottom pivot has been found. ABVC BioPharma, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for ABVC BioPharma, Inc. stock

ABVC BioPharma, Inc. finds support from accumulated volume at $1.05 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0800 between high and low, or 7.48%. For the last week, the stock has had daily average volatility of 10.80%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ABVC) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect ABVC BioPharma, Inc. to open at $1.10, and during the day (based on 14 day Average True Range), to move between $0.94 and $1.22, which gives a possible trading interval of +/-$0.139 (+/-12.87%) up or down from last closing price. If ABVC BioPharma, Inc. takes out the full calculated possible swing range there will be an estimated 25.74% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.05 (2.78%) than the resistance at $1.14 (5.56%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is ABVC BioPharma, Inc. stock A Buy?

ABVC BioPharma, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.370 Sell Candidate Unchanged

Predicted Opening Price for ABVC BioPharma, Inc. of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$1.10 ( 1.85%) $1.08

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ABVC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.18 9.26 %
R2 1.15 6.43 %
R1 1.13 4.68 %
Current price: 1.08
Support S1 1.07 -0.98 %
S2 1.05 -2.73 %
S3 1.02 -5.56 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.28 18.52 %
R2 1.20 11.11 %
R1 1.14 5.56 %
Current price 1.08
Support S1 1.05 -2.78%
S2 1.04 -3.70%
S3 1.02 -5.56%

FAQ

What is the symbol for ABVC BioPharma, Inc. Stock and on which exchange is it traded?
The symbol for ABVC BioPharma, Inc. is ABVC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ABVC BioPharma, Inc. Stock?
ABVC BioPharma, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy ABVC BioPharma, Inc. Stock?
ABVC BioPharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ABVC BioPharma, Inc. Stock.

What's the current price of ABVC BioPharma, Inc. Stock?
As of the end of day on the May 03, 2024, the price of an ABVC BioPharma, Inc. (ABVC) share was $1.08.

What is the 52-week high and low for ABVC BioPharma, Inc. Stock?
The 52-week high for ABVC BioPharma, Inc. Stock is $6.87 and the 52-week low is $0.333.

What is the market capitalization of ABVC BioPharma, Inc. Stock?
As of the May 03, 2024, the market capitalization of ABVC BioPharma, Inc. is 12.144M.

When is the next earnings date for ABVC BioPharma, Inc.?
The upcoming earnings date for ABVC BioPharma, Inc. is Aug 12, 2024.
Click to get the best stock tips daily for free!

About ABVC BioPharma, Inc.

ABVC BioPharma. ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity d... ABVC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT